APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Design

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI Drug Design Industry Growth and Trends Forecast to 2032

4 March 2026102 pages

Choose your research edition.

Industry ResearchAI Drug Design Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Design Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI Drug Design Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Design Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Design Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global AI Drug Design market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Design is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI Drug Design market include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise and Envisagenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI Drug Design market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI Drug Design market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Design market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Design.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI Drug Design market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI Drug Design Market by Company

Exscientia

PathAI

Tempus

Aria Pharmaceuticals

BenchSci

Antidote

AiCure

Atomwise

Envisagenics

Sherlock

Deep Genomics

Benevolent

Iktos

AlmirallShare

AI Drug Design Segment by Type

Therapy Research

Design and Development

Others

AI Drug Design Segment by Application

Cancer

Cardiovascular Disease

Others

AI Drug Design Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Design market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Design and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Design.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI Drug Design companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Design Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI Drug Design Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI Drug Design Market Share by Region (2021-2026) Table 4. Global AI Drug Design Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI Drug Design Market Share by Region (2027-2032) Table 6. Global AI Drug Design Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI Drug Design Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI Drug Design Market Size Share by Type (2021-2026) Table 9. Global AI Drug Design Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI Drug Design Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI Drug Design Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI Drug Design Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI Drug Design Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI Drug Design Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI Drug Design Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI Drug Design Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI Drug Design Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI Drug Design Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI Drug Design Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI Drug Design Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI Drug Design Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI Drug Design Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI Drug Design Market Size Share by Application (2021-2026) Table 24. Global AI Drug Design Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI Drug Design Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI Drug Design Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI Drug Design Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI Drug Design Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI Drug Design Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI Drug Design Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI Drug Design Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI Drug Design Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI Drug Design Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI Drug Design Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI Drug Design Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI Drug Design Industry Trends Table 37. AI Drug Design Industry Drivers Table 38. AI Drug Design Industry Opportunities and Challenges Table 39. AI Drug Design Industry Restraints Table 40. Global AI Drug Design Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI Drug Design Revenue Market Share by Company (2021-2026) Table 42. Global AI Drug Design Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI Drug Design Key Company Headquarters & Area Served Table 44. Global AI Drug Design Company, Product Type & Application Table 45. Global AI Drug Design Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI Drug Design by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Exscientia Company Information Table 49. Exscientia Business Overview Table 50. Exscientia AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Exscientia AI Drug Design Product Portfolio Table 52. Exscientia Recent Development Table 53. PathAI Company Information Table 54. PathAI Business Overview Table 55. PathAI AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. PathAI AI Drug Design Product Portfolio Table 57. PathAI Recent Development Table 58. Tempus Company Information Table 59. Tempus Business Overview Table 60. Tempus AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Tempus AI Drug Design Product Portfolio Table 62. Tempus Recent Development Table 63. Aria Pharmaceuticals Company Information Table 64. Aria Pharmaceuticals Business Overview Table 65. Aria Pharmaceuticals AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Aria Pharmaceuticals AI Drug Design Product Portfolio Table 67. Aria Pharmaceuticals Recent Development Table 68. BenchSci Company Information Table 69. BenchSci Business Overview Table 70. BenchSci AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. BenchSci AI Drug Design Product Portfolio Table 72. BenchSci Recent Development Table 73. Antidote Company Information Table 74. Antidote Business Overview Table 75. Antidote AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Antidote AI Drug Design Product Portfolio Table 77. Antidote Recent Development Table 78. AiCure Company Information Table 79. AiCure Business Overview Table 80. AiCure AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AiCure AI Drug Design Product Portfolio Table 82. AiCure Recent Development Table 83. Atomwise Company Information Table 84. Atomwise Business Overview Table 85. Atomwise AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Atomwise AI Drug Design Product Portfolio Table 87. Atomwise Recent Development Table 88. Envisagenics Company Information Table 89. Envisagenics Business Overview Table 90. Envisagenics AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Envisagenics AI Drug Design Product Portfolio Table 92. Envisagenics Recent Development Table 93. Sherlock Company Information Table 94. Sherlock Business Overview Table 95. Sherlock AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sherlock AI Drug Design Product Portfolio Table 97. Sherlock Recent Development Table 98. Deep Genomics Company Information Table 99. Deep Genomics Business Overview Table 100. Deep Genomics AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Deep Genomics AI Drug Design Product Portfolio Table 102. Deep Genomics Recent Development Table 103. Benevolent Company Information Table 104. Benevolent Business Overview Table 105. Benevolent AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Benevolent AI Drug Design Product Portfolio Table 107. Benevolent Recent Development Table 108. Iktos Company Information Table 109. Iktos Business Overview Table 110. Iktos AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Iktos AI Drug Design Product Portfolio Table 112. Iktos Recent Development Table 113. AlmirallShare Company Information Table 114. AlmirallShare Business Overview Table 115. AlmirallShare AI Drug Design Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AlmirallShare AI Drug Design Product Portfolio Table 117. AlmirallShare Recent Development Table 118. North America AI Drug Design Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America AI Drug Design Market Size by Country (2021-2026) & (US$ Million) Table 120. North America AI Drug Design Market Share by Country (2021-2026) Table 121. North America AI Drug Design Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America AI Drug Design Market Share Forecast by Country (2027-2032) Table 123. Europe AI Drug Design Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe AI Drug Design Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe AI Drug Design Market Share by Country (2021-2026) Table 126. Europe AI Drug Design Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe AI Drug Design Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific AI Drug Design Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific AI Drug Design Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific AI Drug Design Market Share by Country (2021-2026) Table 131. Asia-Pacific AI Drug Design Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific AI Drug Design Market Share Forecast by Country (2027-2032) Table 133. Latin America AI Drug Design Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America AI Drug Design Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America AI Drug Design Market Share by Country (2021-2026) Table 136. Latin America AI Drug Design Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America AI Drug Design Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa AI Drug Design Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa AI Drug Design Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa AI Drug Design Market Share by Country (2021-2026) Table 141. Middle East & Africa AI Drug Design Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa AI Drug Design Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI Drug Design Product Image Figure 3. Global AI Drug Design Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI Drug Design Market Size (2021-2032) & (US$ Million) Figure 5. Global AI Drug Design Market Share by Region: 2025 VS 2032 Figure 6. Global AI Drug Design Market Share by Region (2021-2032) Figure 7. North America AI Drug Design Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI Drug Design Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI Drug Design Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI Drug Design Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI Drug Design Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Therapy Research Image Figure 13. Global Therapy Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Design and Development Image Figure 15. Global Design and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global AI Drug Design Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global AI Drug Design Market Share by Type 2025 VS 2032 Figure 20. North America AI Drug Design Market Size Share by Type (2021-2032) Figure 21. Europe AI Drug Design Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific AI Drug Design Market Size Share by Type (2021-2032) Figure 23. Latin America AI Drug Design Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa AI Drug Design Market Size Share by Type (2021-2032) Figure 25. Cancer Image Figure 26. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Cardiovascular Disease Image Figure 28. Global Cardiovascular Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global AI Drug Design Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global AI Drug Design Market Share by Application 2025 VS 2032 Figure 33. North America AI Drug Design Market Size Share by Application (2021-2032) Figure 34. Europe AI Drug Design Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific AI Drug Design Market Size Share by Application (2021-2032) Figure 36. Latin America AI Drug Design Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa AI Drug Design Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 AI Drug Design Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America AI Drug Design Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America AI Drug Design Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America AI Drug Design Market Share by Country (2021-2032) Figure 43. Europe AI Drug Design Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe AI Drug Design Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe AI Drug Design Market Share by Country (2021-2032) Figure 46. Asia-Pacific AI Drug Design Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific AI Drug Design Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific AI Drug Design Market Share by Country (2021-2032) Figure 49. Latin America AI Drug Design Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America AI Drug Design Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America AI Drug Design Market Share by Country (2021-2032) Figure 52. Middle East & Africa AI Drug Design Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa AI Drug Design Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa AI Drug Design Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Therapy Research
  • Design and Development
  • Others
Applications
  • Cancer
  • Cardiovascular Disease
  • Others
Companies covered
  • Exscientia
  • PathAI
  • Tempus
  • Aria Pharmaceuticals
  • BenchSci
  • Antidote
  • AiCure
  • Atomwise
  • Envisagenics
  • Sherlock
  • Deep Genomics
  • Benevolent
  • Iktos
  • AlmirallShare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI Drug Design Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI Drug Design Market Size by Region (2021-2032)
  5. 1.4.1 Global AI Drug Design Market Size by Region (2021-2026)
  6. 1.4.2 Global AI Drug Design Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI Drug Design Market Size (2021-2032)
  8. 1.5.1 North America AI Drug Design Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI Drug Design Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI Drug Design Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI Drug Design Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI Drug Design Market Size Growth Rate (2021-2032)
2 AI Drug Design Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Therapy Research
  3. 2.1.2 Design and Development
  4. 2.1.3 Others
  5. 2.2 Global AI Drug Design Market Size by Type
  6. 2.2.1 Global AI Drug Design Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global AI Drug Design Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global AI Drug Design Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global AI Drug Design Market Size by Regions
  10. 2.3.1 North America AI Drug Design Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe AI Drug Design Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific AI Drug Design Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America AI Drug Design Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa AI Drug Design Market Size Breakdown by Type (2021-2026)
3 AI Drug Design Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 Cardiovascular Disease
  4. 3.1.3 Others
  5. 3.2 Global AI Drug Design Market Size by Application
  6. 3.2.1 Global AI Drug Design Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global AI Drug Design Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global AI Drug Design Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global AI Drug Design Market Size by Regions
  10. 3.3.1 North America AI Drug Design Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe AI Drug Design Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific AI Drug Design Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America AI Drug Design Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa AI Drug Design Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI Drug Design Industry Trends
  2. 4.2 AI Drug Design Industry Drivers
  3. 4.3 AI Drug Design Industry Opportunities and Challenges
  4. 4.4 AI Drug Design Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI Drug Design Revenue (2021-2026)
  2. 5.2 Global AI Drug Design Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI Drug Design Key Company Headquarters & Area Served
  4. 5.4 Global AI Drug Design Company, Product Type & Application
  5. 5.5 Global AI Drug Design Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI Drug Design Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI Drug Design Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI Drug Design Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Exscientia
  2. 6.1.1 Exscientia Company Information
  3. 6.1.2 Exscientia Business Overview
  4. 6.1.3 Exscientia AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Exscientia AI Drug Design Product Portfolio
  6. 6.1.5 Exscientia Recent Developments
  7. 6.2 PathAI
  8. 6.2.1 PathAI Company Information
  9. 6.2.2 PathAI Business Overview
  10. 6.2.3 PathAI AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 PathAI AI Drug Design Product Portfolio
  12. 6.2.5 PathAI Recent Developments
  13. 6.3 Tempus
  14. 6.3.1 Tempus Company Information
  15. 6.3.2 Tempus Business Overview
  16. 6.3.3 Tempus AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Tempus AI Drug Design Product Portfolio
  18. 6.3.5 Tempus Recent Developments
  19. 6.4 Aria Pharmaceuticals
  20. 6.4.1 Aria Pharmaceuticals Company Information
  21. 6.4.2 Aria Pharmaceuticals Business Overview
  22. 6.4.3 Aria Pharmaceuticals AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Aria Pharmaceuticals AI Drug Design Product Portfolio
  24. 6.4.5 Aria Pharmaceuticals Recent Developments
  25. 6.5 BenchSci
  26. 6.5.1 BenchSci Company Information
  27. 6.5.2 BenchSci Business Overview
  28. 6.5.3 BenchSci AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 BenchSci AI Drug Design Product Portfolio
  30. 6.5.5 BenchSci Recent Developments
  31. 6.6 Antidote
  32. 6.6.1 Antidote Company Information
  33. 6.6.2 Antidote Business Overview
  34. 6.6.3 Antidote AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Antidote AI Drug Design Product Portfolio
  36. 6.6.5 Antidote Recent Developments
  37. 6.7 AiCure
  38. 6.7.1 AiCure Company Information
  39. 6.7.2 AiCure Business Overview
  40. 6.7.3 AiCure AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AiCure AI Drug Design Product Portfolio
  42. 6.7.5 AiCure Recent Developments
  43. 6.8 Atomwise
  44. 6.8.1 Atomwise Company Information
  45. 6.8.2 Atomwise Business Overview
  46. 6.8.3 Atomwise AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Atomwise AI Drug Design Product Portfolio
  48. 6.8.5 Atomwise Recent Developments
  49. 6.9 Envisagenics
  50. 6.9.1 Envisagenics Company Information
  51. 6.9.2 Envisagenics Business Overview
  52. 6.9.3 Envisagenics AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Envisagenics AI Drug Design Product Portfolio
  54. 6.9.5 Envisagenics Recent Developments
  55. 6.10 Sherlock
  56. 6.10.1 Sherlock Company Information
  57. 6.10.2 Sherlock Business Overview
  58. 6.10.3 Sherlock AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sherlock AI Drug Design Product Portfolio
  60. 6.10.5 Sherlock Recent Developments
  61. 6.11 Deep Genomics
  62. 6.11.1 Deep Genomics Company Information
  63. 6.11.2 Deep Genomics Business Overview
  64. 6.11.3 Deep Genomics AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Deep Genomics AI Drug Design Product Portfolio
  66. 6.11.5 Deep Genomics Recent Developments
  67. 6.12 Benevolent
  68. 6.12.1 Benevolent Company Information
  69. 6.12.2 Benevolent Business Overview
  70. 6.12.3 Benevolent AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Benevolent AI Drug Design Product Portfolio
  72. 6.12.5 Benevolent Recent Developments
  73. 6.13 Iktos
  74. 6.13.1 Iktos Company Information
  75. 6.13.2 Iktos Business Overview
  76. 6.13.3 Iktos AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Iktos AI Drug Design Product Portfolio
  78. 6.13.5 Iktos Recent Developments
  79. 6.14 AlmirallShare
  80. 6.14.1 AlmirallShare Company Information
  81. 6.14.2 AlmirallShare Business Overview
  82. 6.14.3 AlmirallShare AI Drug Design Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AlmirallShare AI Drug Design Product Portfolio
  84. 6.14.5 AlmirallShare Recent Developments
7 North America
  1. 7.1 North America AI Drug Design Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI Drug Design Market Size by Country (2021-2026)
  3. 7.3 North America AI Drug Design Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI Drug Design Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI Drug Design Market Size by Country (2021-2026)
  3. 8.3 Europe AI Drug Design Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Drug Design Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI Drug Design Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI Drug Design Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI Drug Design Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI Drug Design Market Size by Country (2021-2026)
  3. 10.3 South America AI Drug Design Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Drug Design Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI Drug Design Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI Drug Design Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst